Acesso livre
Acesso livre

Saúde Pública em Pediatria

Relatório Clínico AAP | Tuberculose em crianças e adolescentes.

2 Dez, 2021 | 11:26h

Tuberculosis Infection in Children and Adolescents: Testing and Treatment – Pediatrics

Relatório Clínico AAP | Promoção da participação de crianças e adolescentes com necessidades especiais em esportes, atividades físicas e de recreação.

1 Dez, 2021 | 15:29h

Promoting the Participation of Children and Adolescents With Disabilities in Sports, Recreation, and Physical Activity – Pediatrics

 

Comentário no Twitter

 

EMA recomenda a aprovação da vacina da Pfizer-BioNTech para crianças de 5 a 11 anos.

26 Nov, 2021 | 12:06h

Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 – European Medicines Agency

Conteúdos relacionados:

RCT: Pfizer vaccine shows 90.7% efficacy for preventing Covid-19 in children 5 to 11 years of age.

What COVID vaccines for young kids could mean for the pandemic.

CDC advisers endorse Pfizer’s Covid-19 vaccine for kids 5-11.

FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children ages 5 to 11.

 

Comentário no Twitter

 

M-A | Sintomas persistentes após infecção por SARS-CoV-2 entre crianças e jovens – “Melhor qualidade de estudo foi associada com menor prevalência de todos os sintomas, exceto perda de olfato e sintomas cognitivos.”

26 Nov, 2021 | 11:58h

Persistent symptoms following SARS-CoV-2 infection among children and young people: a meta-analysis of controlled and uncontrolled studies – Journal of Infection

Conteúdos relacionados:

Review: Long COVID symptoms in children rarely persist beyond three months.

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Long COVID: the physical and mental health of children and non-hospitalized young people after SARS-CoV-2 infection – one in seven children may still have symptoms 15 weeks after infection.

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

Diretriz provisória da OMS sobre a vacinação de crianças e adolescentes contra a COVID-19.

25 Nov, 2021 | 15:20h

Interim statement on COVID-19 vaccination for children and adolescents – World Health Organization

OMS emite diretrizes sobre o tratamento de crianças com síndrome inflamatória multissistêmica associada a COVID-19.

24 Nov, 2021 | 11:37h

Comunicado de imprensa: WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19 – World Health Organization

Diretriz: Living guidance for clinical management of COVID-19 – World Health Organziation

Conteúdos relacionados:

An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.

Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.

Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) alone, IVIG plus glucocorticoids, or glucocorticoids alone.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Cohort study showed that the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) was 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. The incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons.

Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children

Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

SR: Multisystem inflammatory syndrome in children related to COVID-19

Observational study: The combination of Immunoglobulins + Methylprednisolone was associated with a better course of fever compared to Immunoglobulins alone in Multisystem Inflammatory Syndrome in children

ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children

Revisão sistemática | Vacinas para prevenção da diarreia causada por rotavírus.

24 Nov, 2021 | 11:06h

Vaccines for preventing rotavirus diarrhoea: vaccines in use – Cochrane Library

Resumo: Are rotavirus vaccines safe and effective in preventing rotavirus diarrhoea in infants and children? – Cochrane Library

Comentário: Vaccines for preventing rotavirus diarrhoea: an updated Cochrane review – Cochrane Library

Revisão | Prevenção de infecções emergentes em crianças.

23 Nov, 2021 | 15:33h

Prevention of Emerging Infections in Children – Pediatric Clinics of North America

[Ainda não publicado] Pesquisadores afirmam que dose única de vacina contra HPV é altamente eficaz – “Resultado de estudo randomizado e controlado no Quênia traz novo ânimo para eliminar o câncer de colo de útero no mundo.”

22 Nov, 2021 | 09:23h

Single-dose HPV vaccine highly effective, researchers say – University of Washington School of Medicine

Conteúdos relacionados:

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

Editorial | Vacinas contra COVID-19 para crianças – “Embora seja verdade que a maioria das crianças tenham doença assintomática ou leve, algumas ficarão bastante doentes e um pequeno número irá a óbito. Este é o motivo de crianças serem vacinadas contra gripe, meningite, catapora e hepatite.”

19 Nov, 2021 | 13:17h

COVID-19 vaccines for children – Science

Conteúdo relacionado: Review: Should children under 12 years of age be vaccinated against COVID-19?

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.